A ‘Brilinta’ Theory on Why Ticagrelor Doesn’t Work as Well in the U.S. (11 May 2012)
Harry Peled, MDHarry Peled wonders whether intermediate-dose aspirin may simply be so effective that it obviates the need for a P2Y12-receptor antagonist.
CardioExchange has 4,577 members
